Related Experiment Video
Updated: Nov 26, 2025

06:07
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
7.1K
Effect of Intrauterine Smoke Exposure on microRNA-15a Expression in Human Lung Development and Subsequent Asthma Risk
Sunita Sharma1, Alvin T Kho2,3, Divya Chhabra4
1Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.
Healthcare (Basel, Switzerland)
|December 9, 2020
Summary
In utero smoke exposure alters microRNA (miRNA) expression during fetal lung development, linking miR-15a to asthma susceptibility and severity. This suggests a role for miR-15a in the fetal origins of asthma.
Area of Science:
- Developmental Biology
- Genetics
- Immunology
Background:
- In utero smoke (IUS) exposure is a known risk factor for asthma.
- Understanding the molecular mechanisms linking IUS exposure to asthma is crucial.
Purpose of the Study:
- To investigate if changes in microRNA (miRNA) expression due to IUS exposure during human fetal lung development are associated with asthma susceptibility.
- To identify specific miRNAs and their gene targets involved in this process.
Main Methods:
- Gene expression profiling of human fetal lung tissues from IUS-exposed and unexposed groups.
- Differential expression analysis of miRNAs based on post-conception age and IUS exposure.
- Correlation analysis between IUS-associated miRNAs and their gene expression targets.
- Validation in a mouse model and association studies with asthma exacerbations in human cohorts.
Main Results:
- Five miRNAs showed differential expression across post-conception age, with two also differing by IUS exposure in fetal lungs.
- MiR-15a was significantly altered by developmental stage, IUS exposure in fetal lungs, and in postnatal mouse lungs.
- MiR-15a was associated with the intrauterine expression of the asthma gene GSDMB and with asthma exacerbations in a human cohort.
Conclusions:
- MiR-15a is expressed during human lung development, is affected by IUS exposure, and regulates intrauterine expression of asthma-related genes.
- These findings support a role for miR-15a in the fetal origins of asthma, highlighting its potential as a biomarker or therapeutic target.
Related Concept Videos
Asthma-I: Introduction
3.1K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.1K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
699
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
699

